Effect of nasal irrigation in adults infected with Omicron variant of COVID-19: A quasi-experimental study

DOI record: { "DOI": "10.3389/fpubh.2022.1046112", "ISSN": [ "2296-2565" ], "URL": "http://dx.doi.org/10.3389/fpubh.2022.1046112", "abstract": "<jats:sec><jats:title>Objective</jats:title><jats:p>To investigate the effect of nasal irrigation on the duration of symptoms and nucleic acid conversion in adults infected with the Omicron variant of COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This quasi-experimental study enrolled patients diagnosed with asymptomatic, mild, or moderate Omicron infection at the Shandong Public Health Clinical Center between April 1, 2022 and May 1, 2022. Patients were divided into two groups to receive Lianhua Qingwen granules and traditional Chinese medicine (TCM) prescriptions (conventional group) and 3% hypertonic saline nasal irrigation based on conventional treatment (nasal irrigation groups), respectively. Primary outcomes were symptom disappearance time and nucleic acid negative conversion time. Secondary outcomes were peripheral blood white blood cell (WBC), lymphocyte (LYM) count, neutrophil (NEU) count, C-reactive protein (CRP) level, and chest CT examination findings.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Eighty patients were included (40 patients/group). Multiple linear regression analysis showed that, after adjustment for comorbidities, smoking history, LYM count, and Ct values of N gene, the patients in the nasal irrigation group were more likely to get lower nucleic acid negative conversion time (β = −11.052, 95% CI: −8.277–13.827, <jats:italic>P</jats:italic> &amp;lt; 0.001) compared with the conventional group. The symptom disappearance time showed no significant improvement (<jats:italic>P</jats:italic> &amp;gt; 0.05). Subgroup analysis for treatment-naïve patients in the nasal irrigation group showed similar nucleic acid negative conversion time improvement (<jats:italic>P</jats:italic> = 0.038).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Early nasal irrigation shortens the nucleic acid negative conversion time in adults infected with the Omicron variant but without improvements in symptom disappearance time.</jats:p></jats:sec>", "alternative-id": [ "10.3389/fpubh.2022.1046112" ], "author": [ { "affiliation": [], "family": "Liu", "given": "Li", "sequence": "first" }, { "affiliation": [], "family": "Xie", "given": "Shuangshuang", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Cheng", "sequence": "additional" }, { "affiliation": [], "family": "Su", "given": "Liang", "sequence": "additional" }, { "affiliation": [], "family": "Zhu", "given": "Chengbao", "sequence": "additional" } ], "container-title": "Frontiers in Public Health", "container-title-short": "Front. Public Health", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2023, 1, 9 ] ], "date-time": "2023-01-09T13:47:03Z", "timestamp": 1673272023000 }, "deposited": { "date-parts": [ [ 2023, 1, 9 ] ], "date-time": "2023-01-09T13:47:09Z", "timestamp": 1673272029000 }, "funder": [ { "DOI": "10.13039/100016694", "award": [ "2021SFGC0504" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100016694", "id-type": "DOI" } ], "name": "Science and Technology Development Plan of Shandong Province" } ], "indexed": { "date-parts": [ [ 2025, 6, 22 ] ], "date-time": "2025-06-22T08:25:58Z", "timestamp": 1750580758881, "version": "3.37.3" }, "is-referenced-by-count": 5, "issued": { "date-parts": [ [ 2023, 1, 9 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 1, 9 ] ], "date-time": "2023-01-09T00:00:00Z", "timestamp": 1673222400000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fpubh.2022.1046112/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2023, 1, 9 ] ] }, "published-online": { "date-parts": [ [ 2023, 1, 9 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.1001/jama.2020.12839", "article-title": "Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): a review", "author": "Wiersinga", "doi-asserted-by": "publisher", "first-page": "782", "journal-title": "JAMA.", "key": "B1", "volume": "324", "year": "2020" }, { "DOI": "10.1038/s41591-020-0968-3", "article-title": "Extrapulmonary manifestations of COVID-19", "author": "Gupta", "doi-asserted-by": "publisher", "first-page": "1017", "journal-title": "Nat Med.", "key": "B2", "volume": "26", "year": "2020" }, { "DOI": "10.1056/NEJMc2004973", "article-title": "Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1", "author": "van Doremalen", "doi-asserted-by": "publisher", "first-page": "1564", "journal-title": "N Engl J Med.", "key": "B3", "volume": "382", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)32137-1", "article-title": "SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates", "author": "Poland", "doi-asserted-by": "publisher", "first-page": "1595", "journal-title": "Lancet.", "key": "B4", "volume": "396", "year": "2020" }, { "key": "B5", "unstructured": "Coronavirus Disease 2019 (COVID-19)2020" }, { "key": "B6", "unstructured": "Weekly Epidemiological Update on COVID-19—November 16 2022 Edition 1182022" }, { "key": "B7", "unstructured": "SARS-CoV-2 Variant Classifications and Definitions2022" }, { "DOI": "10.3390/biom11070993", "article-title": "COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies", "author": "Raman", "doi-asserted-by": "publisher", "first-page": "993", "journal-title": "Biomolecules.", "key": "B8", "volume": "11", "year": "2021" }, { "DOI": "10.1007/s10989-021-10324-7", "article-title": "ACE2 peptide fragment interaction with different S1 protein sites", "author": "Kuznetsov", "doi-asserted-by": "publisher", "first-page": "7", "journal-title": "Int J Pept Res Ther.", "key": "B9", "volume": "28", "year": "2022" }, { "DOI": "10.4103/ijp.ijp_955_21", "article-title": "Update on omicron variant: what we know so far", "author": "Choudhary", "doi-asserted-by": "publisher", "first-page": "41", "journal-title": "Indian J Pharmacol.", "key": "B10", "volume": "54", "year": "2022" }, { "DOI": "10.1002/mco2.110", "article-title": "SARS-CoV-2 Omicron variant: characteristics and prevention", "author": "He", "doi-asserted-by": "publisher", "first-page": "838", "journal-title": "MedComm.", "key": "B11", "volume": "2", "year": "2021" }, { "DOI": "10.1016/j.lanwpc.2022.100592", "article-title": "Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study", "author": "Chen", "doi-asserted-by": "publisher", "first-page": "100592", "journal-title": "Lancet Reg Health West Pac.", "key": "B12", "volume": "29", "year": "2022" }, { "DOI": "10.1038/s41586-022-04441-6", "article-title": "SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters", "author": "Halfmann", "doi-asserted-by": "publisher", "first-page": "687", "journal-title": "Nature.", "key": "B13", "volume": "603", "year": "2022" }, { "DOI": "10.1016/j.ijsu.2022.106261", "article-title": "The Omicron subvariant BA.2: birth of a new challenge during the COVID-19 pandemic", "author": "Rahimi", "doi-asserted-by": "publisher", "first-page": "106261", "journal-title": "Int J Surg.", "key": "B14", "volume": "99", "year": "2022" }, { "DOI": "10.1056/NEJMc2119270", "article-title": "Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa", "author": "Collie", "doi-asserted-by": "publisher", "first-page": "494", "journal-title": "N Engl J Med.", "key": "B15", "volume": "386", "year": "2022" }, { "DOI": "10.1056/NEJMc2202061", "article-title": "Effectiveness of Ad26.COV2.S and BNT162b2 vaccines against Omicron variant in South Africa", "author": "Gray", "doi-asserted-by": "publisher", "first-page": "2243", "journal-title": "N Engl J Med.", "key": "B16", "volume": "386", "year": "2022" }, { "DOI": "10.1101/2022.02.08.22270685", "article-title": "Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and antigen test sensitivity at commonly sampled anatomic sites over the course of disease", "author": "Lin", "doi-asserted-by": "publisher", "journal-title": "medRxiv.", "key": "B17", "year": "2022" }, { "DOI": "10.1038/s41598-018-37703-3", "article-title": "A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold", "author": "Ramalingam", "doi-asserted-by": "publisher", "first-page": "1015", "journal-title": "Sci Rep.", "key": "B18", "volume": "9", "year": "2019" }, { "DOI": "10.1002/14651858.CD006821.pub3", "article-title": "Saline nasal irrigation for acute upper respiratory tract infections", "author": "King", "doi-asserted-by": "publisher", "first-page": "CD006821", "journal-title": "Cochrane Database Syst Rev.", "key": "B19", "volume": "2015", "year": "2015" }, { "DOI": "10.1017/S0022215108003964", "article-title": "Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study", "author": "Ural", "doi-asserted-by": "publisher", "first-page": "517", "journal-title": "J Laryngol Otol.", "key": "B20", "volume": "123", "year": "2009" }, { "article-title": "The prescribing patterns of Wisconsin family physicians surrounding saline nasal irrigation for upper respiratory conditions", "author": "Rabago", "first-page": "145", "journal-title": "WMJ.", "key": "B21", "volume": "108", "year": "2009" }, { "DOI": "10.1038/s41598-018-31936-y", "article-title": "Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels", "author": "Ramalingam", "doi-asserted-by": "publisher", "first-page": "13630", "journal-title": "Sci Rep.", "key": "B22", "volume": "8", "year": "2018" }, { "DOI": "10.3390/v13081459", "article-title": "SARS-CoV-2, CT-Values, and infectivity-conclusions to be drawn from side observations", "author": "Platten", "doi-asserted-by": "publisher", "first-page": "1459", "journal-title": "Viruses.", "key": "B23", "volume": "13", "year": "2021" }, { "DOI": "10.1186/s12906-017-1585-7", "article-title": "The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function", "author": "Ding", "doi-asserted-by": "publisher", "first-page": "130", "journal-title": "BMC Complement Altern Med.", "key": "B24", "volume": "17", "year": "2017" }, { "DOI": "10.5582/ddt.2020.03054", "article-title": "Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "149", "journal-title": "Drug Discov Ther.", "key": "B25", "volume": "14", "year": "2020" }, { "DOI": "10.3389/fphar.2021.781090", "article-title": "Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment", "author": "Xia", "doi-asserted-by": "publisher", "first-page": "781090", "journal-title": "Front Pharmacol.", "key": "B26", "volume": "12", "year": "2021" }, { "DOI": "10.1007/s11655-022-3578-8", "article-title": "Efficacy and safety of lianhua qingwen for patients with COVID-19: a systematic review and meta-analysis", "author": "Sun", "doi-asserted-by": "publisher", "first-page": "650", "journal-title": "Chin J Integr Med.", "key": "B27", "volume": "28", "year": "2022" }, { "DOI": "10.1016/j.jep.2021.114220", "article-title": "Positive effects of lianhuaqingwen granules in COVID-19 patients: a retrospective study of 248 cases", "author": "Shen", "doi-asserted-by": "publisher", "first-page": "114220", "journal-title": "J Ethnopharmacol.", "key": "B28", "volume": "278", "year": "2021" }, { "journal-title": "Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern", "key": "B29", "year": "2021" }, { "DOI": "10.1016/j.ijid.2022.04.029", "article-title": "Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa", "author": "Liu", "doi-asserted-by": "publisher", "first-page": "146", "journal-title": "Int J Infect Dis.", "key": "B30", "volume": "120", "year": "2022" }, { "DOI": "10.1097/MCP.0000000000000875", "article-title": "Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019", "author": "Hui", "doi-asserted-by": "publisher", "first-page": "166", "journal-title": "Curr Opin Pulm Med.", "key": "B31", "volume": "28", "year": "2022" }, { "DOI": "10.1016/S0140-6736(22)00327-0", "article-title": "Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study", "author": "Menni", "doi-asserted-by": "publisher", "first-page": "1618", "journal-title": "Lancet.", "key": "B32", "volume": "399", "year": "2022" }, { "DOI": "10.1002/jmv.25685", "article-title": "Coronavirus infections and immune responses", "author": "Li", "doi-asserted-by": "publisher", "first-page": "424", "journal-title": "J Med Virol.", "key": "B33", "volume": "92", "year": "2020" }, { "DOI": "10.26355/eurrev_202007_22291", "article-title": "Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy", "author": "De Vito", "doi-asserted-by": "publisher", "first-page": "7861", "journal-title": "Eur Rev Med Pharmacol Sci.", "key": "B34", "volume": "24", "year": "2020" }, { "DOI": "10.1186/s12890-021-01422-9", "article-title": "Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "55", "journal-title": "BMC Pulm Med.", "key": "B35", "volume": "21", "year": "2021" }, { "DOI": "10.1001/jamanetworkopen.2022.10871", "article-title": "Assessment of T-cell reactivity to the SARS-CoV-2 Omicron variant by immunized individuals", "author": "De Marco", "doi-asserted-by": "publisher", "first-page": "e2210871", "journal-title": "JAMA Netw Open.", "key": "B36", "volume": "5", "year": "2022" }, { "DOI": "10.1038/s41586-022-04479-6", "article-title": "SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo", "author": "Hui", "doi-asserted-by": "publisher", "first-page": "715", "journal-title": "Nature", "key": "B37", "volume": "603", "year": "2022" }, { "DOI": "10.1001/jamaoto.2020.1622", "article-title": "Benefits and safety of nasal saline irrigations in a pandemic-washing COVID-19 away", "author": "Farrell", "doi-asserted-by": "publisher", "first-page": "787", "journal-title": "JAMA Otolaryngol Head Neck Surg.", "key": "B38", "volume": "146", "year": "2020" }, { "DOI": "10.7189/jogh.10.010332", "article-title": "Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19", "author": "Ramalingam", "doi-asserted-by": "publisher", "first-page": "010332", "journal-title": "J Glob Health.", "key": "B39", "volume": "10", "year": "2020" } ], "reference-count": 39, "references-count": 39, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fpubh.2022.1046112/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Effect of nasal irrigation in adults infected with Omicron variant of COVID-19: A quasi-experimental study", "type": "journal-article", "update-policy": "https://doi.org/10.3389/crossmark-policy", "volume": "10" }